Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray for prevention of postoperative delirium in elderly gastrointestinal cancer surgery
ChiCTR2500106763Phase 4Not yet recruiting
- Sponsor
- Affiliated Cancer Hospital of Guangzhou Medical University
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in postoperative delirium (POD) (2 arms), sponsored by Affiliated Cancer Hospital of Guangzhou Medical University. Primary endpoint: Incidence of postoperative delirium. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2500106763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106763.